Clinical trial
International, Multicenter, Open-label Clinical Study of Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Participants With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
NCT07880886 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- International, Multicenter, Open-label Clinical Study of Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Participants With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
- Lead sponsor
- R-Pharm
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- April 30, 2030
- Enrollment
- 18 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.